ArticleSensors (Basel, Switzerland)2025
Design and Optimization of an Inductive-Stub-Coupled CSRR for Non-Invasive Glucose Sensing.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Patch-Type Microwave Resonant Sensor Based on a Complementary Split-Ring Resonator for Monitoring Glucose Concentration Under Static and Dynamic Conditions.Sensors (Basel, Switzerland) · 2026Article
- Design of an Ultra-Sensitive Multi-Resonant Moore Fractal SRR Microwave Sensor for Non-Invasive Blood Glucose Monitoring.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents a high-sensitivity microwave sensor based on a modified Complementary Split Ring Resonator (CSRR) architecture, integrated with inductive stubs, for non-invasive blood glucose monitoring. The proposed sensor is designed to enhance the electric field localization and coupling efficiency by introducing inductive elements that strengthen the perturbation effect caused by glucose concentration changes in the blood. Numerical simulations were conducted using a multilayer finger model to evaluate the sensor's performance under various glucose levels ranging from 0 to 500 mg/dL. The modified sensor exhibits dual-resonance characteristics and outperforms the conventional CSRR in both frequency and amplitude sensitivity. At an optimized stub gap of 2 mm, which effectively minimizes the capacitive coupling effect of the transmission line and thereby improves the quality factor, the sensor achieves a frequency shift sensitivity of 0.086 MHz/mg/dL and an amplitude sensitivity of 0.02 dB/mg/dL, compared to 0.032 MHz/mg/dL and 0.0116 dB/mg/dL observed in the standard CSRR structure. This confirms a significant enhancement in sensing performance and field confinement due to the optimized inductive loading. These results represent significant enhancements of approximately 168% and 72%, respectively. With its compact design, increased sensitivity, and potential for wearable implementation, the proposed sensor offers a promising platform for continuous, real-time, and non-invasive glucose monitoring in biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.